Pressrelease – Lund, March 17th, 2026 – Hamlet BioPharmas digital monthly investor meeting on the 18th of March

Hamlet Biopharma
|
March 17, 2026

Hamlet BioPharma invites you to our monthly investors’ meeting to be held on the 18th of March 2026, at 12:00.

Please click on the link below to participate in the meeting

https://us06web.zoom.us/j/87443477663?pwd=3QfpaU8RvYGIxlqF2o8uDEmIpX2mwM.1


For further information, please contact:

Catharina Svanborg, Chairman of the board, Hamlet BioPharma, +46-709 42 65 49
catharina.svanborg@hamletpharma.com

Jakob Testad, CEM, Hamlet BioPharma, +46-708 48 42 10
jakob.testad@hamletbiopharma.com

www.hamletbiopharma.com

An innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections.
Hamlet BioPharma AB
Klinikgatan 32
SE-222 42 Lund
info@hamletbiopharma.com
Org. no. 556568-8958
Subscribe to receive
Pressreleases and Newsletters
© 2026
Hamlet BioPharma.